Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model
- PMID: 21052913
- DOI: 10.1007/s10384-010-0838-5
Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model
Abstract
Purpose: To compare the effect of three intracameral antibiotics, gentamicin (GM), gatifloxacin (GFLX), and moxifloxacin (MFLX), on the rabbit corneal endothelium.
Methods: Twenty-four eyes from 18 rabbits were used. In the GM treatment group of 12 eyes, a dose of 20 mg/ml, 2 mg/ml, 200 μg/ml, or 20 μg/ml of GM was injected into the anterior chamber. In the GFLX and MFLX treatment groups were injected into the anterior chamber of three eyes. The central corneal thickness was measured. The eyes were then enucleated for observation under scanning electron microscopy.
Results: Three days after the intracameral injection, a significant difference in central corneal thickness was found between the GM 20 mg/ml group and the control group (P < 0.05), but not between any other groups. The damage rate at the endothelial cell level was 67% in the GM 20 mg/ml group, 56% in the GM 2 mg/ml group, 33% in the GM 200 μg/ml group, 22% in the GM 20 μg/ml group, 22% in the GFLX group, and 0% in the MFLX group.
Conclusions: Intracameral GFLX or MFLX was almost nontoxic to the rabbit corneal endothelium, in contrast to the toxic results of intracameral GM 20 and 2 mg/ml.
Similar articles
-
Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells.Clin Exp Ophthalmol. 2008 May;36(4):367-70. doi: 10.1111/j.1442-9071.2008.01771.x. Clin Exp Ophthalmol. 2008. PMID: 18700925
-
Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols.Cornea. 2005 Jan;24(1):66-71. doi: 10.1097/01.ico.0000134182.09569.e1. Cornea. 2005. PMID: 15604869
-
Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability.J Ocul Pharmacol Ther. 2009 Oct;25(5):425-31. doi: 10.1089/jop.2009.0010. J Ocul Pharmacol Ther. 2009. PMID: 19857104
-
Safety of intracameral injection of moxifloxacin using total replacement technique (bag and chamber flushing).J Ocul Pharmacol Ther. 2014 Nov;30(9):771-6. doi: 10.1089/jop.2014.0029. Epub 2014 Aug 21. J Ocul Pharmacol Ther. 2014. PMID: 25144127 Clinical Trial.
-
Safety of moxifloxacin as shown in animal and in vitro studies.Surv Ophthalmol. 2005 Nov;50 Suppl 1:S46-54. doi: 10.1016/j.survophthal.2005.05.003. Surv Ophthalmol. 2005. PMID: 16257310 Review.
Cited by
-
Evaluation of moxifloxacin-induced cytotoxicity on human corneal endothelial cells.Sci Rep. 2021 Mar 18;11(1):6250. doi: 10.1038/s41598-021-85834-x. Sci Rep. 2021. PMID: 33737688 Free PMC article.
-
Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracamaral use of cefuroxime.Clin Ophthalmol. 2015 Mar 17;9:493-7. doi: 10.2147/OPTH.S74249. eCollection 2015. Clin Ophthalmol. 2015. PMID: 25834384 Free PMC article.
-
Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease.Int J Ophthalmol. 2013 Aug 18;6(4):471-4. doi: 10.3980/j.issn.2222-3959.2013.04.12. eCollection 2013. Int J Ophthalmol. 2013. PMID: 23991381 Free PMC article.
-
Gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis: safety, efficacy and patient perspective.Ophthalmol Eye Dis. 2012 Jul 11;4:65-70. doi: 10.4137/OED.S7383. Print 2012. Ophthalmol Eye Dis. 2012. PMID: 23650458 Free PMC article.
-
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.Br J Ophthalmol. 2018 Sep;102(9):1268-1276. doi: 10.1136/bjophthalmol-2017-311051. Epub 2018 Jan 11. Br J Ophthalmol. 2018. PMID: 29326317 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical